Pro-inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis

Cover Page

Cite item

Full Text

Abstract

The review summarizes the current understanding of the role of cytokines in the pathogenesis of osteoarthritis. The imbalance of pro-inflammatory and anti-inflammatory cytokines in the joint tissues leads to the development of inflammation and cartilage damage, which leads to progressive degeneration of the joints.

About the authors

Kirill V. Raymuev

North-Western State Medical University named after I.I. Mechnikov

Author for correspondence.
Email: r-kn@mail.ru
ORCID iD: 0000-0002-0559-2899
SPIN-code: 1907-1669

кандидат медицинских наук доцент кафедры терапии и эндокринологии

Russian Federation, 41, Kirochnaya street, Saint-Petersburg, 191015

References

  1. Мазуров В.И., Трофимова А.С., Трофимов Е.А. Факторы риска и некоторые аспекты патогенеза остео артрита // Вестник СЗГМУ им. И.И. Мечникова. – 2016. – № 2. – С. 116–125. [Mazurov VI, Trofimova AS, Trofimov EA. Faktory riska I nekotorye aspekty patogeneza osteoartrita. Herald of North-Western State Medical University named after I.I. Mechnikov. 2016;(2):116-125. (In Russ.)]
  2. Лила А.М. Остеоартрит // Ревматология. Фармакотерапия без ошибок: руководство для врачей / Под ред. В.И. Мазурова, О.М. Лесняк. – М.: Е-ното, 2017. – 528 с. [Lila AM. Osteoartrit. In: Revmatologiya. Farmakoterapiya bez oshibok: rukovodstvo dlya vrachei. Ed by V.I. Mazurova, O.M. Lesnyak. Moscow: E-noto; 2017. 528 p. (In Russ.)]
  3. Haseeb А, Haggi T. Immunopathogenesis of osteoarthritis. Clin Immunol. 2013;146(3):185-196. doi: 10.1016/j.clim.2012.12.011.
  4. Goldring MB, Otero M. Inflammation in osteoarthritis. Current Opinion in Rheumatology. 2011;23(5):471-478. doi: 10.1097/BOR.0b013e328349c2b1.
  5. Dinarello CA. Overview of the interleukin-1 family of ligands and receptors. Semin Immunol. 2013;25(6):389-393. doi: 10.1016/j.smim.2013.10.001.
  6. de Lange-Brokaar BJ, Ioan-Facsinay A, van Osch GJ, et al. Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review. Osteoarthritis Cartilage. 2012;20(12):1484-1499. doi: 10.1016/j.joca.2012.08.027.
  7. Sohn DH, Sokolove J, Sharpe O, et al. Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4. Arthritis Research and Therapy. 2012;14(1):R7. doi: 10.1186/ar3555.
  8. Boraschi D, Tagliabue A. The interleukin-1 receptor family. Seminars in Immunology. 2013;25(6):394-407. doi: 10.1016/j.smim.2013.10.023.
  9. Sadouk MB, Pelletier JP, Tardif G, et al. Human synovial fibroblasts coexpress IL-1 receptor type I and type II mRNA: the increased level of the IL-1 receptor in osteoarthritic cells is related to an increased level of the type I receptor. Laboratory Investigation. 1995;73(3):347-355.
  10. Kawai T, Akira S. TLR signaling. Seminars in Immunology. 2007;19(1):24-32.
  11. Roman-Blas JA, Jimenez SA. NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthritis and Cartilage. 2006;14(9):839-848. doi: 10.1016/j.joca.2006.04.008.
  12. Marcu KB, Otero M, Olivotto E, et al. NF-κB signaling: multiple angles to target OA. Current Drug Targets. 2010;11(5):599-613.
  13. Shakibaei M, Shulze-Tanzil G, John T, et al. Curcumin protects human chondrocytes from IL-1β-induced inhibition of collagen type II and β1-integrin expression and activition of caspase-3: an immunomorphological study. Annals of Anatomy. 2005;187(5-6):487-497.
  14. Самойлов В.В., Мироманов А.М., Самойлова С.И. Значение цитокинов в патогенезе остеоартроза // Забайкальский медицинский вестник. – 2014. – № 2. – С. 119–125. [Samoilov VV, Miromanov AM, Samoi lova SI. Znachenie tsitokinov v patogeneze osteo artroza. Zabaikal’skii meditsinskii vestnik. 2014;(2):199-125. (In Russ.)]
  15. Verma P, Dalal K. ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis. Journal of Cellular Biochemistry. 2011;112(12):3507-3514. doi: 10.1002/jcb.23298.
  16. López-Armada MJ, Carames B, Lires Dean M, et al. Cytokines, tumor necrosis factor-α and interleukin-1β, differentially regulate apoptosis in osteoarthritis cultured human chondrocytes. Osteoarthritis and Cartilage. 2006;14(7):660-669. doi: 10.1016/j.joca.2006.01.005.
  17. Afonso V, Champy R, Mitrovic D, et al. Reactive oxygen species and superoxide dismutases: role in joint diseases. Joint Bone Spine. 2007;74(4):324-329. doi: 10.1016/j.jbspin.2007.02.002.
  18. Bodmer JL, Schneider P, Tshopp J. The molecular architecture of the TNF superfamily. Trends in Biochemical Sciences. 2002;27(1):19-26.
  19. MacEwan DJ. TNF receptor subtype signalling: differences and cellular consequences. Cellular Signalling. 2002;14(6):477-492.
  20. Haas TL, Emmerich CH, Gerlach B, et al. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and Is required for TNF-mediated gene induction. Molecular Cell. 2009;36(5):-844. doi: 10.1016/j.molcel.2009.10.013.
  21. Varfolomeev E, Goncharov T, Fedorova AV, et al. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor α (TNFα)-induced NF-κB activation. Journal of Biological Chemistry. 2008;283(36):24295-24299. doi: 10.1074/jbc.C800128200.
  22. Micheau O, Tshopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell. 2003;114(2):181-190.
  23. Rodríguez M, Cabal-Hierro L, Carcedo MT, et al. NF-κB signal triggering and termination by tumor necrosis factor receptor 2. Journal of Biological Che mistry. 2011;286(26):22814-22824. doi: 10.1074/jbc.M111.225631.
  24. Oregón-Romero E, Vázquez-Del Mercado M, Navarro-Hernández RE, et al. Tumor necrosis factor receptor 2 M196R polymorphism in rheumatoid arthritis and osteoarthritis: relationship with sTNFR2 levels and clinical features. Rheumatology International. 2006;27(1):53-59. doi: 10.1007/s00296-006-0159-7.
  25. Liu CJ, Bosch X. Progranulin: a growth factor, a novel TNFR ligand and a drug target. Pharmacology & Therapeutics. 2012;133(1):124-132. doi: 10.1016/j.pharmthera.2011.10.003.
  26. Jian J, Konopka J, Liu C. Insights into the role of progranulin in immunity, infection, and inflammation. Journal of Leukocyte Biology. 2013;93(2):199-208. doi: 10.1189/jlb.0812429.
  27. Séguin CA, Bernier SM. TNF-alpha suppresses link protein and type II collagen expression in chondrocytes: role of MEK1/2 and NF-kappaB signaling pathways. Journal of Cellular Physiology. 2003;197(3):356-369. doi: 10.1002/jcp.10371.
  28. Ye Z, Chen Y, Zhang R, et al. c-Jun N-terminal kinase — c-Jun pathway transactivates Bim to promote osteoarthritis. Canadian Journal of Physiology and Pharmacology. 2014;92(2):132-139. doi: 10.1139/cjpp-2013-0228.
  29. Honorati MC, Cattini L, Facchini A. VEGF production by osteoarthritic chondrocytes cultured in micromass and mulated by IL-17 and TNF-α. Connective Tissue Research. 2007;48(5):239-245. doi: 10.1080/ 03008200701541767.
  30. Distel E, Cadoudal T, Durant S, et al. The infrapatellar fat pad in knee osteoarthritis: an important source of interleukin-6 and its soluble receptor. Arthritis and Rheumatism. 2009;60(11):3374-3377. doi: 10.1002/art.24881.
  31. Stannus O, Jones G, Cicuttini F, et al. Circulating levels of IL-6 and TNF-α are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Osteoarthritis and Cartilage. 2010;18(11):1441-1447. doi: 10.1016/j.joca.2010.08.016.
  32. Rose-John S, Neurath MF. IL-6 trans-signaling: the heat is on. Immunity. 2004;20(1):2-4.
  33. Kamimura D, Isihara K, Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Reviews of Physiology, Biochemistry and Pharmacology. 2003;149:1-38. doi: 10.1007/s10254-003-0012-2.
  34. Honsawek S, Deepaisarnsakul B, Tanavalee A, et al. Association of the IL-6 -174G/C gene polymorphism with knee osteoarthritis in a Thai population. Genetics and Molecular Research. 2011;10(3):1674-1680.
  35. Porée B, Kypriotou M, Chadjichristos C, et al. Interleukin-6 (IL-6) and/or soluble IL-6 receptor down-regulation of human type II collagen gene expression in articular chondrocytes requires a decrease of Sp1·Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter. Journal of Biological Chemistry. 2008;283(8):4850-4865. doi: 10.1074/jbc.M706387200.
  36. Steeve KT, Marc P, Sandrine T, et al. RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine and Growth Factor Reviews. 2004;15(1):49-60.
  37. Sakao K, Takahashi KA, Arai Y, et al. Osteoblasts derived from osteophytes produce interleukin-6, interleukin-8, and matrix metalloproteinase-13 in osteoarthritis. Journal of Bone and Mineral Metabolism. 2009;27(4):412-423. doi: 10.1007/s00774-009-0058-6.
  38. de Hooge ASK, van de Loo FAJ, Bennink MB. Male IL-6 gene knock out mice developed more advanced osteoarthritis upon aging. Osteoarthritis and Cartilage. 2005;13(1):66-73. doi: 10.1016/j.joca.2004.09.011.
  39. Baslund B,Tvede N, Danneskiold-Samsoe B, et al Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. Arthritis and Rheumatism. 2005;52(9):2686-2692. doi: 10.1002/art.21249.
  40. Scanzello CR, Umoh E, Pessler F, et al. Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease. Osteoarthritis and Cartilage. 2009;17(8):1040-1048. doi: 10.1016/j.joca.2009.02.011.
  41. Sun JM, Sun LZ, Liu J. Serum interleukin-15 levels are associated with severity of pain in patients with knee osteoarthritis. Disease Markers. 2013;35(3):203-206. doi: 10.1155/2013/176278.
  42. Chang SH, Dong C. Signaling of interleukin-17 fa mily cytokines in immunity and inflammation. Cell Signaling. 2011;23(7):1069-1075. doi: 10.1016/j.cellsig.2010.11.022.
  43. Korn T, Bettelli E, Oukka M, et al. IL-17 and Th17 cells. Annual Review of Immunology. 2009;27:485-517. doi: 10.1146/annurev.immunol.021908.132710.
  44. Chen B, Deng Y, Tan Y. Association between severity of knee osteoarthritis and serum and synovial fluid interleukin 17 concentrations. Journal of International Medical Research. 2014;42(1):138-144. doi: 10.1177/0300060513501751.
  45. Benderdour M, Tardif G, Pelletier JP, et al. Interleukin 17 (IL-17) induces collagenase-3 production in human osteoarthritic chondrocytes via AP-1 dependent activation: differential activation of AP-1 members by IL-17 and IL-1β. Journal of Rheumatology. 2002;29(6):1262-1272.
  46. Honorati MC, Bovara M, Cattini L, et al. Contribution of interleukin 17 to human cartilage degradation and synovial inflammation in osteoarthritis. Osteoarthritis and Cartilage. 2002;10(10):799-807.
  47. Han L, Lee HS, Yoon JH, et al. Association of IL-17A and IL-17F single nucleotide polymorphisms with susceptibility to osteoarthritis in a Korean population. Gene. 2014;533(1):119-122. doi: 10.1016/j.gene.2013.09.113.
  48. Möller B, Kukoc-Zivojnov N, Kessler U, et al. Interferon-gamma induces expression of interleukin-18 binding protein in fibroblast-like synoviocytes. Rheumatology. 2003;42(3):442-445.
  49. Denoble AE, Huffman KM, Stabler TV, et al. Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(5):2088-2093. doi: 10.1073/pnas.1012743108.
  50. Hulin-Curtis SL, Bidwell JL, Perry MJ. Evaluation of IL18 and IL18R1 polymorphisms: genetic susceptibility to knee osteoarthritis. International Journal of Immunogenetics. 2012;39(2):106-109. doi: 10.1111/j.1744-313X.2011.01060.x.
  51. Dai SM, Shan ZZ, Nishioka K, et al. Implication of interleukin 18 in production of matrix metalloproteinases in articular chondrocytes in arthritis: direct effect on chondrocytes may not be pivotal. Annals of the Rheumatic Diseases. 2005;64(5):735-742. doi: 10.1136/ard.2004.026088.
  52. John T, Kohl B, Mobasheri A, et al. Interleukin-18 induces apoptosis in human articular chondrocytes. Histology and Histopathology. 2007;22(5):469-482. doi: 10.14670/HH-22.469.
  53. Mueller TD, Zhang JL, Sebald W, et al. Structure, binding, and antagonists in the IL-4/IL-13 receptor system. Biochimica et Biophysica Acta-Molecular Cell Research. 2002;1592(3):237-250.
  54. Bhattacharjee A, Shukla M, Yakubenko VP, et al. IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages. Free Radical Biology & Medicine. 2013;54:1-16. doi: 10.1016/j.freeradbiomed.2012.10.553.
  55. Yigit S, Inanir A, Tekcan A, et al. Significant association of interleukin-4 gene intron 3 VNTR polymorphism with susceptibility to knee osteoarthritis. Gene. 2014;537(1):6-9. doi: 10.1016/j.gene.2013.12.060.
  56. Wagner S, Fritz P, Einsele H, et al. Evaluation of synovial cytokine patterns in rheumatoid arthritis and osteo arthritis by quantitative reverse transcription polymerase chain reaction. Rheumatology International. 1997;16(5):191-196.
  57. van Meegeren ME, Roosendaal G, Jansen NW, et al. IL-4 alone and in combination with IL-10 protects against blood-induced cartilage damage. Osteoarthritis and Cartilage. 2012;20(7):764-772. doi: 10.1016/j.joca.2012.04.002.
  58. Yorimitsu M, Nishida K, Shimizu A, et al. Intra-articular injection of interleukin-4 decreases nitric oxide production by chondrocytes and ameliorates subsequent destruction of cartilage in instability-induced osteoarthritis in rat knee joints. Osteoarthritis and Cartilage. 2008;16(7):764-771. doi: 10.1016/ j.joca.2007.11.006.
  59. Donnelly RP, Dickensheets H, Finbloom DS. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocyte s. Journal of Interferon and Cytokine Research. 1999;19(6):563-573. doi: 10.1089/107999099313695.
  60. Wang Y, Lou S. Direct protective effect of interleukin-10 on articular chondrocytes in vitro. Chinese Medical Journal. 2001;114(7):723-725.
  61. John T, Müller RD, Oberholzer A, et al. Interleukin-10 modulates pro-apoptotic effects of TNF-α in human arti cular chondrocytes in vitro. Cytokine. 2007;40(3):226-234. doi: 10.1016/j.cyto.2007.10.002.
  62. Lacraz S, Nicod LP, Chicheportiche R, et al. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. Journal of Clinical Investigation. 1995;96(5):2304-2310. doi: 10.1172/JCI118286.
  63. Umulis D, O’Connor MB, Blair SS. The extracellular regulation of bone morphogenetic protein signaling. Development. 2009;136(22):3715-3728. doi: 10.1242/dev.031534.
  64. Yeh LA, Augustine AJ, Lee P, et al. Interleukin-4, an inhibitor of cartilage breakdown in bovine articular cartilage explants . Journal of Rheumatology. 1995;22(9):1740-1746.
  65. Crane JL, Cao XJ. Bone marrow mesenchymal stem cells and TGF-beta signaling in bone remodeling. Clin Invest. 2014;124:466-472. doi: 10.1172/JCI70050.

Copyright (c) 2018 Raymuev K.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies